{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:39:19Z","timestamp":1790786359394,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Japanese Society of Peritoneal Dialysis"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07717"],"award-info":[{"award-number":["23K07717"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19129"],"award-info":[{"award-number":["24K19129"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15227"],"award-info":[{"award-number":["23K15227"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08310"],"award-info":[{"award-number":["22K08310"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16189"],"award-info":[{"award-number":["21K16189"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15226"],"award-info":[{"award-number":["23K15226"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19gm1210009"],"award-info":[{"award-number":["19gm1210009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004017","name":"Japanese Association of Dialysis Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004017","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kyoto Health Care Society"},{"DOI":"10.13039\/501100012029","name":"Tsuchiya Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71859-5","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:09:19Z","timestamp":1726052959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deletion of p38 MAPK in macrophages ameliorates peritoneal fibrosis and inflammation in peritoneal dialysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Akie","family":"Ikushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita P.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Sugioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"71859_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/CN108382","volume":"83","author":"JP Teixeira","year":"2015","unstructured":"Teixeira, J. P., Combs, S. A. & Teitelbaum, I. Peritoneal dialysis: Update on patient survival. Clin. Nephrol. 83, 1\u201310 (2015).","journal-title":"Clin. Nephrol."},{"key":"71859_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10157-011-0471-8","volume":"15","author":"M Mizuno","year":"2011","unstructured":"Mizuno, M. et al. Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin. Exp. Nephrol. 15, 727\u2013737 (2011).","journal-title":"Clin. Exp. Nephrol."},{"key":"71859_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","volume":"11","author":"SJ Davies","year":"1996","unstructured":"Davies, S. J., Bryan, J., Phillips, L. & Russell, G. I. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol. Dial Transplant. 11, 498\u2013506 (1996).","journal-title":"Nephrol. Dial Transplant."},{"key":"71859_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams, J. D. et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 13, 470\u2013479 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"71859_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3747\/pdi.2011.00332","volume":"34","author":"K Farhat","year":"2014","unstructured":"Farhat, K., Stavenuiter, A. W., Beelen, R. H. & Ter Wee, P. M. Pharmacologic targets and peritoneal membrane remodeling. Perit. Dial Int. 34, 114\u2013123 (2014).","journal-title":"Perit. Dial Int."},{"key":"71859_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1523-1755.2001.059002463.x","volume":"59","author":"H Ha","year":"2001","unstructured":"Ha, H., Yu, M. R. & Lee, H. B. High glucose-induced PKC activation mediates TGF-\u03b21 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int. 59, 463\u2013470 (2001).","journal-title":"Kidney Int."},{"key":"71859_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/14.6.1541","volume":"14","author":"K Honda","year":"1999","unstructured":"Honda, K. et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol. Dial Transplant. 14, 1541\u20131549 (1999).","journal-title":"Nephrol. Dial Transplant."},{"key":"71859_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas, B. & Nebreda, A. R. Diversity and versatility of p38 kinase signalling in health and disease. Nat. Rev. Mol. Cell Biol. 22, 346\u2013366 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"71859_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","volume":"68","author":"PP Roux","year":"2004","unstructured":"Roux, P. P. & Blenis, J. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320\u2013344 (2004).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"71859_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado, A. & Nebreda, A. R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403\u2013417 (2010).","journal-title":"Biochem. J."},{"key":"71859_CR11","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000165117.71483.0C","volume":"111","author":"M Li","year":"2005","unstructured":"Li, M. et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation. 111, 2494\u20132502 (2005).","journal-title":"Circulation."},{"key":"71859_CR12","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/art.22080","volume":"54","author":"A Korb","year":"2006","unstructured":"Korb, A. et al. Differential tissue expression and activation of p38 MAPK \u03b1, \u03b2, \u03b3, and \u03b4 isoforms in rheumatoid arthritis. Arthritis Rheum. 54, 2745\u20132756 (2006).","journal-title":"Arthritis Rheum."},{"key":"71859_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/10799893.2014.896380","volume":"34","author":"H Amano","year":"2014","unstructured":"Amano, H. et al. p38 Mitogen-activated protein kinase accelerates emphysema in mouse model of chronic obstructive pulmonary disease. J. Recept. Signal. Transduct. Res. 34, 299\u2013306 (2014).","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"71859_CR14","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/febs.13250","volume":"282","author":"J Gupta","year":"2015","unstructured":"Gupta, J. & Nebreda, A. R. Roles of p38\u03b1 mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. FEBS J. 282, 1841\u20131857 (2015).","journal-title":"FEBS J."},{"key":"71859_CR15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.kint.2023.08.010","volume":"104","author":"T Ishimura","year":"2023","unstructured":"Ishimura, T. et al. Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFkappaBeta pathway inhibition. Kidney Int. 104, 929\u2013942 (2023).","journal-title":"Kidney Int."},{"key":"71859_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3747\/pdi.2010.00200","volume":"32","author":"S Kokubo","year":"2012","unstructured":"Kokubo, S. et al. Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes. Perit. Dial Int. 32, 10\u201319 (2012).","journal-title":"Perit. Dial Int."},{"key":"71859_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin, T. & Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11\u201318 (2005).","journal-title":"Cell Res."},{"key":"71859_CR18","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1046\/j.1523-1755.1998.00177.x","volume":"54","author":"S Yung","year":"1998","unstructured":"Yung, S. & Davies, M. Response of the human peritoneal mesothelial cell to injury: An in vitro model of peritoneal wound healing. Kidney Int. 54, 2160\u20132169 (1998).","journal-title":"Kidney Int."},{"key":"71859_CR19","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1523-1755.2005.00179.x","volume":"67","author":"K Kiribayashi","year":"2005","unstructured":"Kiribayashi, K. et al. Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1\/2 and p38 MAPK. Kidney Int. 67, 1126\u20131135 (2005).","journal-title":"Kidney Int."},{"key":"71859_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1046\/j.1523-1755.2003.00836.x","volume":"63","author":"ZG Xu","year":"2003","unstructured":"Xu, Z. G. et al. High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Kidney Int. 63, 958\u2013968 (2003).","journal-title":"Kidney Int."},{"key":"71859_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2013.81","volume":"84","author":"T Ueno","year":"2013","unstructured":"Ueno, T. et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-\u03b21 signaling. Kidney Int. 84, 297\u2013307 (2013).","journal-title":"Kidney Int."},{"key":"71859_CR22","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1093\/ndt\/gfr068","volume":"26","author":"T Kushiyama","year":"2011","unstructured":"Kushiyama, T. et al. Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats. Nephrol. Dial. Transplant. 26, 3143\u20133154 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"71859_CR23","doi-asserted-by":"publisher","unstructured":"Allen, M. et al. Deficiency of the stress kinase p38\u03b1 results in embryonic lethality: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191(5), 859\u2013870. https:\/\/doi.org\/10.1084\/jem.191.5.859 (2000).","DOI":"10.1084\/jem.191.5.859"},{"key":"71859_CR24","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1681\/ASN.2004121084","volume":"16","author":"M Koshikawa","year":"2005","unstructured":"Koshikawa, M. et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 16, 2690\u20132701 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"71859_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.12688\/f1000research.22092.1","volume":"9","author":"J Han","year":"2020","unstructured":"Han, J., Wu, J. & Silke, J. An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling. F1000Res. 9, 653 (2020).","journal-title":"F1000Res."},{"key":"71859_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2019.03.014","volume":"71","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Macrophage p38\u03b1 promotes nutritional steatohepatitis through M1 polarization. J. Hepatol. 71, 163\u2013174 (2019).","journal-title":"J. Hepatol."},{"key":"71859_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/ni.1640","volume":"9","author":"C Kim","year":"2008","unstructured":"Kim, C. et al. p38\u03b1 MAP kinase serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 9, 1019\u20131027 (2008).","journal-title":"Nat. Immunol."},{"key":"71859_CR28","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.4049\/jimmunol.176.6.3635","volume":"176","author":"NJ Horwood","year":"2006","unstructured":"Horwood, N. J. et al. Bruton\u2019s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J. Immunol. 176, 3635\u20133641 (2006).","journal-title":"J. Immunol."},{"key":"71859_CR29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1074\/jbc.273.3.1741","volume":"273","author":"H Enslen","year":"1998","unstructured":"Enslen, H., Raingeaud, J. & Davis, R. J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273, 1741\u20131748 (1998).","journal-title":"J. Biol. Chem."},{"key":"71859_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/ng2037","volume":"39","author":"JJ Ventura","year":"2007","unstructured":"Ventura, J. J. et al. p38\u03b1 MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750\u2013758 (2007).","journal-title":"Nat. Genet."},{"key":"71859_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1008942828960","volume":"8","author":"BE Clausen","year":"1999","unstructured":"Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265\u2013277 (1999).","journal-title":"Transgenic Res."},{"key":"71859_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ki.2011.305","volume":"81","author":"H Yokoi","year":"2012","unstructured":"Yokoi, H. et al. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int. 81, 160\u2013169 (2012).","journal-title":"Kidney Int."},{"key":"71859_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100050","volume":"103","author":"S Kunoki","year":"2023","unstructured":"Kunoki, S. et al. Inhibition of transglutaminase 2 reduces peritoneal injury in a chlorhexidine-induced peritoneal fibrosis model. Lab. Investig. 103, 100050 (2023).","journal-title":"Lab. Investig."},{"key":"71859_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.kint.2023.06.007","volume":"104","author":"S Sugioka","year":"2023","unstructured":"Sugioka, S. et al. Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi. Kidney Int. 104, 508\u2013525 (2023).","journal-title":"Kidney Int."},{"key":"71859_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.ki.5002722","volume":"73","author":"H Yokoi","year":"2008","unstructured":"Yokoi, H. et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int. 73, 446\u2013455 (2008).","journal-title":"Kidney Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71859-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71859-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71859-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:13:05Z","timestamp":1726053185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71859-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71859-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H. Yokoi has received Speakers Bureau from AstraZeneca. M. Yanagita has received research grants from Mitsubishi Tanabe Pharmaceutical Corporation and Boehringer Ingelheim. All remaining authors declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The human sample study was approved by the Ethics Committee for Human Research of the Graduate School of Medicine, Kyoto University (Approval No. R3781). All animal experiments were conducted in accordance with the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions and were approved by the Animal Experimentation Committee of Kyoto University Graduate School of Medicine (Approval number; MedKyo23154). All methods were carried out in accordance with relevant guidelines and regulations including ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"21220"}}